{"id":1104,"date":"2021-01-31T09:24:38","date_gmt":"2021-01-31T09:24:38","guid":{"rendered":"https:\/\/adreshe.com\/?p=1104"},"modified":"2024-09-09T10:43:46","modified_gmt":"2024-09-09T10:43:46","slug":"economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life","status":"publish","type":"post","link":"https:\/\/adreshe.com\/en\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/","title":{"rendered":"Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life"},"content":{"rendered":"

Bagnasco D, Povero M, Pradelli L, Brussino L, Rolla G, Caminati M, Menzella F, Heffler E, Canonica GW, Paggiaro P, Senna G, Milanese M, Lombardi C, Bucca C, Manfredi A, Canevari RF, Passalacqua G; SANI Network (Severe Asthma Network Italy). – World Allergy Organ J. 2021 Jan 27;14(2):100509<\/p>","protected":false},"excerpt":{"rendered":"

Bagnasco D, Povero M, Pradelli L, Brussino L, Rolla G, Caminati M, Menzella F, Heffler E, Canonica GW, Paggiaro P, Senna G, Milanese M, Lombardi C, Bucca C, Manfredi A, Canevari RF, Passalacqua G; SANI Network (Severe Asthma Network Italy). – World Allergy Organ J. 2021 Jan 27;14(2):100509<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[56,8],"tags":[],"class_list":["post-1104","post","type-post","status-publish","format-standard","hentry","category-56","category-articoli"],"yoast_head":"\nEconomic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life - Adres<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/adreshe.com\/en\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life - Adres\" \/>\n<meta property=\"og:description\" content=\"Bagnasco D, Povero M, Pradelli L, Brussino L, Rolla G, Caminati M, Menzella F, Heffler E, Canonica GW, Paggiaro P, Senna G, Milanese M, Lombardi C, Bucca C, Manfredi A, Canevari RF, Passalacqua G; SANI Network (Severe Asthma Network Italy). – World Allergy Organ J. 2021 Jan 27;14(2):100509\" \/>\n<meta property=\"og:url\" content=\"https:\/\/adreshe.com\/en\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/\" \/>\n<meta property=\"og:site_name\" content=\"Adres\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-31T09:24:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-09T10:43:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/adreshe.com\/wp-content\/uploads\/2025\/03\/AdRes.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/#\\\/schema\\\/person\\\/9099f9d808254da1a35de846dff135f5\"},\"headline\":\"Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life\",\"datePublished\":\"2021-01-31T09:24:38+00:00\",\"dateModified\":\"2024-09-09T10:43:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\\\/\"},\"wordCount\":58,\"publisher\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/#organization\"},\"articleSection\":[\"2021\",\"ARTICOLI\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\\\/\",\"url\":\"https:\\\/\\\/adreshe.com\\\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\\\/\",\"name\":\"Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life - Adres\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/#website\"},\"datePublished\":\"2021-01-31T09:24:38+00:00\",\"dateModified\":\"2024-09-09T10:43:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/adreshe.com\\\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/adreshe.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/#website\",\"url\":\"https:\\\/\\\/adreshe.com\\\/\",\"name\":\"Adres\",\"description\":\"Health Economics & Outcomes Research\",\"publisher\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/adreshe.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/#organization\",\"name\":\"Adres - Health Economic & Outcome Research\",\"url\":\"https:\\\/\\\/adreshe.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/adreshe.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Logo-AdRes-rgb.png\",\"contentUrl\":\"https:\\\/\\\/adreshe.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/Logo-AdRes-rgb.png\",\"width\":1754,\"height\":874,\"caption\":\"Adres - Health Economic & Outcome Research\"},\"image\":{\"@id\":\"https:\\\/\\\/adreshe.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/adreshe.com\\\/#\\\/schema\\\/person\\\/9099f9d808254da1a35de846dff135f5\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/adreshe.com\\\/en\\\/author\\\/ecappelluti_vr1q5683\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life - Adres","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/adreshe.com\/en\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/","og_locale":"en_US","og_type":"article","og_title":"Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life - Adres","og_description":"Bagnasco D, Povero M, Pradelli L, Brussino L, Rolla G, Caminati M, Menzella F, Heffler E, Canonica GW, Paggiaro P, Senna G, Milanese M, Lombardi C, Bucca C, Manfredi A, Canevari RF, Passalacqua G; SANI Network (Severe Asthma Network Italy). – World Allergy Organ J. 2021 Jan 27;14(2):100509","og_url":"https:\/\/adreshe.com\/en\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/","og_site_name":"Adres","article_published_time":"2021-01-31T09:24:38+00:00","article_modified_time":"2024-09-09T10:43:46+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/adreshe.com\/wp-content\/uploads\/2025\/03\/AdRes.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/adreshe.com\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/#article","isPartOf":{"@id":"https:\/\/adreshe.com\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/"},"author":{"name":"admin","@id":"https:\/\/adreshe.com\/#\/schema\/person\/9099f9d808254da1a35de846dff135f5"},"headline":"Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life","datePublished":"2021-01-31T09:24:38+00:00","dateModified":"2024-09-09T10:43:46+00:00","mainEntityOfPage":{"@id":"https:\/\/adreshe.com\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/"},"wordCount":58,"publisher":{"@id":"https:\/\/adreshe.com\/#organization"},"articleSection":["2021","ARTICOLI"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/adreshe.com\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/","url":"https:\/\/adreshe.com\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/","name":"Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life - Adres","isPartOf":{"@id":"https:\/\/adreshe.com\/#website"},"datePublished":"2021-01-31T09:24:38+00:00","dateModified":"2024-09-09T10:43:46+00:00","breadcrumb":{"@id":"https:\/\/adreshe.com\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/adreshe.com\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/adreshe.com\/economic-impact-of-mepolizumab-in-uncontrolled-severe-eosinophilic-asthma-in-real-life\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/adreshe.com\/"},{"@type":"ListItem","position":2,"name":"Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life"}]},{"@type":"WebSite","@id":"https:\/\/adreshe.com\/#website","url":"https:\/\/adreshe.com\/","name":"Adres","description":"Health Economics & Outcomes Research","publisher":{"@id":"https:\/\/adreshe.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/adreshe.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/adreshe.com\/#organization","name":"Adres - Health Economic & Outcome Research","url":"https:\/\/adreshe.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/adreshe.com\/#\/schema\/logo\/image\/","url":"https:\/\/adreshe.com\/wp-content\/uploads\/2024\/01\/Logo-AdRes-rgb.png","contentUrl":"https:\/\/adreshe.com\/wp-content\/uploads\/2024\/01\/Logo-AdRes-rgb.png","width":1754,"height":874,"caption":"Adres - Health Economic & Outcome Research"},"image":{"@id":"https:\/\/adreshe.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/adreshe.com\/#\/schema\/person\/9099f9d808254da1a35de846dff135f5","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/536df349161af16e37ed88238229a18c093837210c4d74bcdf5340a0b17b22eb?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/adreshe.com\/en\/author\/ecappelluti_vr1q5683\/"}]}},"_links":{"self":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts\/1104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/comments?post=1104"}],"version-history":[{"count":1,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts\/1104\/revisions"}],"predecessor-version":[{"id":1105,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/posts\/1104\/revisions\/1105"}],"wp:attachment":[{"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/media?parent=1104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/categories?post=1104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adreshe.com\/en\/wp-json\/wp\/v2\/tags?post=1104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}